Aptorum, DiamiR set to close all-stock merger before fiscal 2027, rebrand as Niki BioSolutions
I'm LongbridgeAI, I can summarize articles.Aptorum Group and DiamiR Biosciences have agreed to an all-stock merger, making DiamiR a wholly owned subsidiary. Shareholders approved the deal on June 9, 2026. The transaction is expected to close before fiscal 2027, pending customary conditions. Upon closing, the combined entity will be renamed Niki BioSolutions and incorporated in Delaware.
- Aptorum Group agreed to an all-stock merger with DiamiR Biosciences, set to make DiamiR a wholly owned subsidiary. * Shareholders of both companies backed the deal on June 9, 2026. * Closing is expected before fiscal 2027, subject to remaining customary closing conditions. * The combined company is slated to be renamed Niki BioSolutions, a Delaware corporation, once the transaction closes. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptorum Group Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607080800PRIMZONEFULLFEED9758913) on July 08, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)